XML 45 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Carrying and Estimated Fair Value of Other Financial Instruments
The following tables present the carrying amounts and estimated fair values of our financial instruments by hierarchy level as of March 31, 2023 and December 31, 2022:
March 31, 2023
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities
Acquisition-related contingent consideration (1)
$13,080 $— $— $13,080 
2023 Convertible Notes (2)
315,583 — 616,368 — 
Total$328,663 $— $616,368 $13,080 
December 31, 2022
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities   
Acquisition-related contingent consideration (1)
$14,988 $— $— $14,988 
2023 Convertible Notes (2)
315,172 — 509,682 — 
Total$330,160 $— $509,682 $14,988 
(1)The short-term portion is included in “Accounts payable, accrued expenses and other” and the long-term portion is included in “Other liabilities” on the Condensed Consolidated Balance Sheets.
(2)The carrying amount includes unamortized deferred debt issuance costs.
Schedule of Change in Liability for our Level 3 Financial Instruments
The change in our liability for our Level 3 financial instruments is as follows:
Contingent Consideration
Balance at December 31, 2022$14,988 
Accretion expense (1)
$1,284 
Payments(3,430)
Foreign currency translation adjustment (2)
238 
Balance at March 31, 2023$13,080 
Contingent Consideration
Balance at December 31, 2021$15,110 
Additions$5,370 
Accretion expense (1)
(979)
Payments(4,430)
Foreign currency translation adjustment (2)
(115)
Balance at March 31, 2022$14,956 
(1)Accretion expense is included in SG&A expenses on the Condensed Consolidated Statements of Comprehensive Income.
(2)Foreign currency translation adjustments are included in “Other comprehensive income (loss), net of tax” on the Condensed Consolidated Statements of Comprehensive Income.